コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 The primary end point was progression-free survival.
2 The primary end point was progression-free survival.
3 The primary end point was progression-free survival.
4 The primary end point was progression-free survival.
5 The primary end point was progression-free survival.
6 The primary end point was progression-free survival.
7 The primary end point was progression-free survival according to the Response Eva
8 The primary end point was progression-free survival as assessed by independent re
9 The primary end point was progression-free survival,
as assessed by means of blin
10 The primary end point was progression-free survival assessed by independent radio
11 The primary end point was progression-free survival based on blinded, independent
12 The primary end point was progression-free survival by response assessment in neu
13 The primary end point was progression-free survival,
defined as the time to disea
14 The primary end point was progression-free survival,
for which the study had 90%
15 The primary end point was progression-free survival in an intention-to-treat anal
16 The primary end point was progression-free survival in the intent-to-treat popula
17 The primary end point was progression-free survival (
PFS) after random assignment
18 The primary end point was progression-free survival (
PFS) assessed by independent
19 The primary end point was progression-free survival (
PFS) assessed by modified Re
20 The primary end point was progression-free survival (
PFS) at 12 weeks, with 12-we
21 The primary end point was progression-free survival (
PFS) at 6 months.
22 The primary end point was progression-free survival (
PFS) at any site as assessed
23 The primary end point was progression-free survival (
PFS) by independent radiolog
24 The primary end point was progression-free survival (
PFS) by independent radiolog
25 The primary end point was progression-free survival (
PFS) by independent review.
26 The primary end point was progression-free survival (
PFS) by RECIST.
27 The primary end point was progression-free survival (
PFS) by RECIST; secondary en
28 The primary end point was progression-free survival (
PFS) from random assignment
29 The primary end point was progression-free survival (
PFS) in the beta3T-positive
30 The primary end point was progression-free survival (
PFS) in the HER2-positive po
31 The primary end point was progression-free survival (
PFS) in triplet (MPR and CPR
32 The primary end point was progression-free survival (
PFS) rate at 6 months.
33 The primary end point was progression-free survival (
PFS) within the oxaliplatin
34 The primary end point was progression-free survival (
PFS), determined by independ
35 The primary end point was progression-free survival (
PFS), using a phase 2.5 stat
36 The primary end point was progression-free survival (
PFS).
37 The primary end point was progression-free survival (
PFS).
38 The primary end point was progression-free survival (
PFS).
39 The primary end point was progression-free survival (
PFS).
40 The primary end point was progression-free survival (
PFS).
41 The primary end point was progression-free survival (
PFS).
42 The primary end point was progression-free survival (
PFS).
43 The primary end point was progression-free survival (
PFS).
44 The primary end point was progression-free survival (
PFS).
45 The primary end point was progression-free survival (
PFS); secondary efficacy end
46 The primary end point was progression-free survival (
PFS); secondary end points i
47 The primary end point was progression-free survival (
PFS); secondary end points i
48 The primary end point was progression-free-survival (
PFS).
49 The primary end point was progression-free survival with continuous lenalidomide-
50 The primary end point was progression-free survival,
with overall survival design
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。